RE: Beware Of Hype Thou Even Big Pharma Can Be FooI have to agree...I have not been impressed with the way this company has executed release of news...they have been quite selective with what they think is important for investors to know instead of strategic telling the entire development story. Why did they release news of patent issuance in India without first indicating intent to proceed with clinical trials in India? The website is unimpressive and does very little to create investor confidence. I agree - SSS needs to focus on what they know, and resist from throwing our random information that is not part of the primary NTX 265 stroke program.
Do I think there is the potential for upside here ? Definitely. I like this stock, and will continue to invest - but I am disappointed in the performance.